Annual report pursuant to Section 13 and 15(d)

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.7.0.1
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Increase in cost of goods sold due to reclassification   $ 377,316
Decrease in selling, general and administrative expenses due to reclassifcation   377,316
Net loss $ (14,141,298) (12,233,128)
Cash flows from operations (2,053,740) (4,208,267)
Impairment of intangible assets 2,746,512 0
Cash in excess of FDIC limits 518,066  
Allowance for doubtful accounts 100,000 100,000
Shipping and handling 497,227 377,316
Allowance for customer returns 0 0
Inventory, noncurrent 6,478,727 0
Inventory write-down 3,562,459 0
Depreciation expense 195,167 190,335
Research and development 1,159,009 1,320,003
Advertising expense 311,217 190,800
Unrecognized tax benefits 0 0
Consumer Products [Member]    
Impairment of intangible assets (2,746,512)  
Inventory write-down 3,562,459  
Research and development 834,963 1,320,003
Specialty Pharmaceuticals [Member]    
Impairment of intangible assets 0  
Inventory write-down 0  
Research and development $ 324,046 $ 0
Options [Member]    
Stock options outstanding that are antidilutive 15,591,000 9,799,036
Warrants [Member]    
Stock options outstanding that are antidilutive 2,100,000  
Common Stock [Member] | Performance-Based Stock Options [Member]    
Stock options outstanding that are antidilutive 11,000,000  
Common Stock [Member] | Contingent Consideration [Member]    
Stock options outstanding that are antidilutive 15,000,000  
Accounts Receivable [Member] | One Customer [Member]    
Concentration risk percentage 58.00%  
Accounts Receivable [Member] | Two Customers [Member]    
Concentration risk percentage   83.00%
Sales Revenue, Net [Member] | Two Customers [Member]    
Concentration risk percentage   30.00%
Germany and The Netherlands [Member]    
Inventory, noncurrent $ 680,515